Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Prescribed treatments for myelodysplastic syndromes (MDS)
Locations
3
Singapore
Local Institution - 0003
Singapore, Singapore
Local Institution - 002
Seoul, Seoul Teugbyeolsi, South Korea
Local Institution - 0001
Taipei, Taiwan
Start Date
March 26, 2026
Primary Completion Date
October 31, 2026
Completion Date
September 30, 2027
Last Updated
February 13, 2026
NCT06465953
NCT06398457
NCT06886425
NCT07516847
NCT01660607
NCT05048498
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
855-907-3286Clinical.Trials@bms.comFirst line of the email MUST contain NCT # and Site #.
CONTACT
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions